The effectiveness of psychological interventions for fatigue in cancer survivors: systematic review of randomised controlled trials
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background: Fatigue is a common symptom in cancer patients that can persist beyond the curative treatment phase. This systematic review evaluated the effectiveness of psychological interventions for cancer-related fatigue in post-treatment cancer survivors. Methods: We searched relevant online databases and sources of grey literature. Randomised controlled trials (RCTs) evaluating psychological interventions in adult cancer patients after the completion of treatment, with fatigue as an outcome measure, were included. Two review authors extracted data independently from the selected studies and assessed the methodological quality using the Cochrane Collaboration Risk of Bias Tool. Results: Thirty-three psychological interventions were identified. The sample size of the included studies varied between 28 and 409, with 4525 participants overall. Twenty-three of the included studies reported a significant effect of the interventions on reducing fatigue in cancer survivors. Most interventions focused on psychoeducation, mindfulness, cognitive or behaviour therapy-oriented strategies. However, studies differed widely in terms of measurement tools used to assess fatigue, mode, duration and frequency of the intervention delivery. Conclusions: This review showed some tentative support for psychological interventions for fatigue after cancer treatment. However, as the RCTs were heterogeneous in nature and the number of high-quality studies was limited, definitive conclusions are not yet possible. With the growing need for stage-specific research in cancer, this review sought to inform current practice and to summarise the existing evidence base of randomised controlled trials in the area. Systematic review registration: PROSPERO registration number: CRD42014015219.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339
Developing and evaluating complex interventions: the new Medical Research Council guidance
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2013) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2012.09.010 · Cited by 1,658
Mustian, K. M., Alfano, C. M., Heckler, C., Kleckner, A. S., Kleckner, I. R., Leach, C. R., Mohr, D., Palesh, O. G., Peppone, L. J., Piper, B. F., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6914 · Cited by 932
Bower, J. E., Bak, K., Berger, A., Breitbart, W., Escalante, C. P., Ganz, P. A., Schnipper, H. H., Lacchetti, C., Ligibel, J. A., Lyman, G. H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.4495 · Cited by 671
Hoffman, C. J., Ersser, S. J., Hopkinson, J. B., Nicholls, P. G., Harrington, J. E., & Thomas, P. W. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0331 · Cited by 398 · cited 1×
“Hoffman 2012 [30] pOMSF/I 214 103 111 12–14 weeks There were statistically significant differences between treatment groups for POMS fatigue p = 0.002 [8 weeks only] Difference Between Groups at T2 adjusted for baseline mean = − 2.68; 95% CI = [− 4.31 to − 1.04] Difference between groups at T3…”
BackgroundInfluentialMindfulness meditation for younger breast cancer survivors: A randomized controlled trial
Bower, J. E., Crosswell, A. D., Stanton, A. L., Crespi, C. M., Winston, D., Arevalo, J., Ma, J., Cole, S. W., & Ganz, P. A. (2015) · Cancer · doi:10.1002/cncr.29194 · Cited by 390 · cited 1×
“Bower 2015 [17] Fatigue Symptom Inventory 71 39 32 3 months Mindfulness led to significant improvements in fatigue (p = 0.007), from pre- to post-intervention.”
BackgroundInfluentialEspie, C. A., Fleming, L., Cassidy, J., Samuel, L., Taylor, L. M., White, C. A., Douglas, N. J., Engleman, H. M., Kelly, H.-L., & Paul, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9006 · Cited by 383 · cited 1×
“Espie 2008 [23] FSI 150 100 50 6 months p 0.001 (Standardized Effect =− 0.82) CBT participants had reduced symptoms of fatigue relative to TAU.”
BackgroundInfluentialJohnson, J. A., Rash, J. A., Campbell, T. S., Savard, J., Gehrman, P. R., Perlis, M., Carlson, L. E., & Garland, S. N. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.07.001 · Cited by 371
Gielissen, M. F. M., Verhagen, S., Witjes, F., & Bleijenberg, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8270 · Cited by 349 · cited 2×
“There were no differences between LD and TD. Gielissen 2006 [28] Fatigue severity subscale of the CIS 98 50 48 6 months Patients in the intervention condition reported a significantly greater decrease than patients in the waiting list condition in fatigue severity (difference, 13.3; 95% CI, 8.6 to 18.1) Table 3 Summar…”
BackgroundInfluentialRitterband, L. M., Bailey, E. T., Thorndike, F. P., Lord, H. R., Farrell‐Carnahan, L., & Baum, L. D. (2012) · Psycho-Oncology · doi:10.1002/pon.1969 · Cited by 296 · cited 1×
“Ritterband 2012 [36] Multidimensional Fatigue Symptom Inventory- Short Form (MFSI-SF) 28 14 14 9 weeks p 0.01 Overall adjusted ES (d) = 1.16 A significant group × time interaction was found for the overall measure of fatigue, MFSI-SF (F1,26 = 13.88, p 0.01).”
MethodInfluentialCarlson, L. E., Doll, R., Stephen, J., Faris, P., Tamagawa, R., Drysdale, E., & Speca, M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.5210 · Cited by 282 · cited 2×
“The remainder were conducted in Australia, [34, 38] Canada [39, 45], Germany [47], France [22, 25] and Korea [42, 43].”
BackgroundLengacher, C. A., Reich, R. R., Paterson, C. L., Ramesar, S., Park, J. Y., Alinat, C., Johnson-Mallard, V., Moscoso, M., Budhrani-Shani, P., Miladinovic, B., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7874 · Cited by 255 · cited 1×
“…n intervention n Control Final followup Finding intervention effects were observed Mean difference (95% CI) = 1.1 (− 2.4, 4.5) p = 0.527 Reich 2017/ Lengacher 2016 [35, 46] Fatigue Symptom Inventory 303 155 148 12 weeks MBSR(BC) demonstrated greater symptom improvement in fatigue (severity and…”
BackgroundInfluentialEfficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors
Dirksen, S. R., & Epstein, D. R. (2008) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2007.04560.x · Cited by 185 · cited 1×
“Group-by-time effect at intervention (6months): p = 0.001 95% CI − 0.45 [− 0.70; − 0.20] Group-by-time effect at follow-up (12 months) p = 0.76 Dirksen 2008 [20] Profile of Mood States Fatigue/ Inertia Subscale (POMSF/I) 72 34 38 2 weeks Statistically significant pre- to post-treatment change (p <…”
InfluentialMindfulness‐based cognitive therapy reduces chronic cancer‐related fatigue: a treatment study
van der Lee, M. L., & Garssen, B. (2012) · Psycho-Oncology · doi:10.1002/pon.1890 · Cited by 178 · cited 2×
“Pooled data (n = 57) 3-month follow-up : adjusted mean= 2.33; 95% CI = 2.15 to 2.51 6-month follow-up: adjusted mean = 2.25; 95% CI = 2.07 to 2.43 12-month follow-up: adjusted mean = 2.18; 95% CI = 1.98 to 2.38 Van Der Lee 2012 [40] Multidimensional Fatigue Inventory (MFI)- General fatigue 83 59 24 6 months p < 0.001…”
BackgroundInfluentialCarlson, L. E., Tamagawa, R., Stephen, J., Drysdale, E., Zhong, L., & Speca, M. (2016) · Psycho-Oncology · doi:10.1002/pon.4150 · Cited by 170
Lengacher, C. A., Reich, R. R., Post-White, J., Moscoso, M., Shelton, M. M., Barta, M., Le, N., & Budhrani, P. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-011-9346-4 · Cited by 170 · cited 1×
“…Pooled SD = 2.01 Effect size=− 1.34 95% CI effect size = [1.88, − 0.81] FSI severity p* ≤ 0.001 Pooled SD = 1.51 Effect size =− 1.54 95% CI effect size = [− 2.10, − 0.97] Lengacher 2012 [31] Symptom Inventory (MDASI) 84 41 43 6 week p 0.5 P (between-group post-assessment) p = 0.05 At…”
InfluentialJohns, S. A., Brown, L. F., Beck‐Coon, K., Monahan, P. O., Tong, Y., & Kroenke, K. (2015) · Psycho-Oncology · doi:10.1002/pon.3648 · Cited by 161
Dolbeault, S., Cayrou, S., Brédart, A., Viala, A. L., Desclaux, B., Saltel, P., Gauvain‐Piquard, A., Hardy, P., & Dickes, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1440 · Cited by 160
A Brief Intervention for Fatigue Management in Breast Cancer Survivors
Fillion, L., Gagnon, P., Leblond, F., Gélinas, C., Savard, J., Dupuis, R., Duval, K., & Larochelle, M. (2008) · Cancer Nursing · doi:10.1097/01.ncc.0000305698.97625.95 · Cited by 128 · cited 1×
“…at the 2- month follow-up time point suggested that MAAT participants demonstrated sustained clinical gains compared with ST participants (0.46) Fillion 2008 [25] Multidimensional Fatigue Inventory 87 44 43 3 months Marginal Group x Time interaction effects: p = 0 .07; Cohen d = 0.36…”
BackgroundInfluentialRogers, L. Q., Courneya, K. S., Anton, P. M., Verhulst, S., Vicari, S. K., Robbs, R. S., & McAuley, E. (2017) · Psycho-Oncology · doi:10.1002/pon.4254 · Cited by 108
Matthews, E. E., Berger, A. M., Schmiege, S. J., Cook, P. F., McCarthy, M. S., Moore, C. M., & Aloia, M. S. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.41-03ap · Cited by 103 · cited 1×
“Matthews 2014 [32] Piper Fatigue Scale 56 30 26 6 week p = 0.76 d = 0.2 No group differences in improvement were noted relative to fatigue.”
BackgroundInfluentialReif, K., de Vries, U., Petermann, F., & Görres, S. (2013) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2012.07.002 · Cited by 83 · cited 11×
“…week d = 0.27 95% CI 12 0.07 to 0.47 Fatigue—interference (FSI) p = 0 .006T2 week d = 0.3 95% CI [0.10 to 0.51 ]T3 week d = 0.23 95% CI [0.02 to 0.43] Reif 2013 [47] Fatigue Assessment Questionnaire (FAQ) and Fatigue subscale of the EORTCQLQ-C30 234 120 114 6 months FAQ : Significant reduction in…”
BackgroundMethodInfluentialReeves, M., Winkler, E., Mccarthy, N., Lawler, S., Terranova, C., Hayes, S., Janda, M., Demark-Wahnefried, W., & Eakin, E. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12629 · Cited by 58 · cited 6×
“The Brief Fatigue Inventory (BFI) was used in five studies [14, 17, 26, 29, 43] and the Functional Assessment in Cancer Therapy-Fatigue (FACIT-F) was used in five studies [16, 24, 27, 29, 34].”
BackgroundMethodInfluentialYun, Y. H., Kim, Y. A., Lee, M. K., Sim, J. A., Nam, B.-H., Kim, S., Lee, E. S., Noh, D.-Y., Lim, J.-Y., Kim, S., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3290-9 · Cited by 47 · cited 1×
“Yun 2017 [42] EORTC QLQ-C30 fatigue score 174 57 117 12 months From baseline to 12 months, the LP group, relative to the UC group, showed a significantly greater decrease in the EORTC QLQ-C30 fatigue score (p = 0.065) 3 months: p = 0.214 12 months: p value = 0.010** Yun 2012 [43] Brief Fatigue…”
MethodInfluentialHabibović, M., Cuijpers, P., Alings, M., van der Voort, P., Theuns, D., Bouwels, L., Herrman, J.-P., Valk, S., & Pedersen, S. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.2809 · Cited by 47 · cited 7×
“Dolbeault 2009 [22] POMSF/I and EORTC Fatigue 167 81 86 6 months Comparison of change scores between randomisation arms (Group: n=81; Control: n=87) POMS fatigue • Group: E1 Mean (SD) 10.01 (7.38) ; E3 Mean (SD) 6.86 (5.58) ; Intra-subject p = -0.069 Eta2= 0.02 • Control: E1 Mean (SD) 8.78 (6.85); E3 Mean (SD) 8.87 (6…”
Influential
Cited by
Management of common clinical problems experienced by survivors of cancer
Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00242-2 · Cited by 326
Maunick, B., Skvarc, D., Olive, L., & Mikocka-Walus, A. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111366 · Cited by 21
Neubert, S., Schlecht, S., Meng, K., Rabe, A., & Jentschke, E. (2023) · Integrative Cancer Therapies · doi:10.1177/15347354231153172 · Cited by 20
Psychoedukation mit Krebspatienten: Hintergrund und wissenschaftliche Evidenz
Weis, J., & Heckl, U. (2021) · Der Onkologe · doi:10.1007/s00761-020-00878-4 · Cited by 15
Taylor, H., Kingston, J., & Taylor, M. D. (2024) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2024.100849 · Cited by 3
Metadata
- Authors
- Corbett, T. K., Groarke, A., Devane, D., Carr, E., Walsh, J. C., & McGuire, B. E.
- Venue
- Systematic Reviews
- Published
- 2019-12
- Volume
- 8
- Issue
- 1
- Pages
- 324-324
- ISSN
- 2046-4053 (ISSN-L)
- OpenAlex
- W2995550480
- Cited by
- 97
- References
- 27
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.